|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/26/24 AVROBIO, Inc. S-4/A 3/25/24 89:18M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: S-4/A Pre-Effective Amendment to Registration Statement HTML 6.92M
- Securities for a Merger
2: EX-5.1 Opinion of Counsel re: Legality HTML 29K
3: EX-10.35 Material Contract HTML 164K
4: EX-10.36 Material Contract HTML 177K
5: EX-10.37 Material Contract HTML 93K
6: EX-10.38 Material Contract HTML 112K
7: EX-10.39 Material Contract HTML 190K
8: EX-10.40 Material Contract HTML 149K
9: EX-21.1 Subsidiaries List HTML 23K
10: EX-23.1 Consent of Expert or Counsel HTML 24K
11: EX-23.2 Consent of Expert or Counsel HTML 24K
13: EX-FILING FEES Filing Fees HTML 44K
12: EX-99.10 Miscellaneous Exhibit HTML 27K
24: R1 Cover Page HTML 59K
25: R2 Consolidated Balance Sheets HTML 114K
26: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K
27: R4 Consolidated Statements Of Operations And HTML 84K
Comprehensive Income (Loss)
28: R5 Consolidated Statements of Stockholders' Equity HTML 66K
29: R6 Consolidated Statements of Cash Flows HTML 118K
30: R7 Nature of the Business HTML 36K
31: R8 Summary of Significant Accounting Policies HTML 70K
32: R9 License and Purchase Agreements HTML 51K
33: R10 Fair Value of Financial Assets and Liabilities HTML 49K
34: R11 Supplemental Balance Sheet Information HTML 62K
35: R12 Leases HTML 44K
36: R13 Note Payable HTML 40K
37: R14 Common Stock HTML 49K
38: R15 Stock-Based Compensation HTML 78K
39: R16 401(k) Savings Plan HTML 31K
40: R17 Commitments and Contingencies HTML 34K
41: R18 Income Taxes HTML 73K
42: R19 Net Income (Loss) per Share HTML 50K
43: R20 Related Party Transactions HTML 32K
44: R21 Restructuring HTML 37K
45: R22 Subsequent Events HTML 30K
46: R23 Summary of Significant Accounting Policies HTML 109K
(Policies)
47: R24 Summary of Significant Accounting Policies HTML 29K
(Tables)
48: R25 Fair Value of Financial Assets and Liabilities HTML 48K
(Tables)
49: R26 Supplemental Balance Sheet Information (Tables) HTML 67K
50: R27 Leases (Tables) HTML 43K
51: R28 Note Payable (Tables) HTML 31K
52: R29 Common Stock (Tables) HTML 41K
53: R30 Stock-Based Compensation (Tables) HTML 68K
54: R31 Income Taxes (Tables) HTML 67K
55: R32 Net Income (Loss) per Share (Tables) HTML 51K
56: R33 Restructuring (Tables) HTML 32K
57: R34 Nature of the Business - Additional Information HTML 44K
(Detail)
58: R35 Summary of Significant Accounting Policies - HTML 39K
Additional Information (Detail)
59: R36 Summary of Significant Accounting Policies - HTML 35K
Schedule of Property and Equipment Estimated
Useful Life (Detail)
60: R37 License and Purchase Agreements - Additional HTML 104K
Information (Detail)
61: R38 Fair Value of Financial Assets and Liabilities - HTML 35K
Summary of Financial Assets and Liabilities
Measured at Fair Value on Recurring Basis (Detail)
62: R39 Fair Value of Financial Assets and Liabilities - HTML 27K
Additional Information (Detail)
63: R40 Supplemental Balance Sheet Information - Summary HTML 37K
of Prepaid Expenses and Other Current Assets
(Detail)
64: R41 Supplemental Balance Sheet Information - Summary HTML 44K
of Property and Equipment, Net (Detail)
65: R42 Supplemental Balance Sheet Information - HTML 28K
Additional Information (Detail)
66: R43 Supplemental Balance Sheet Information - Summary HTML 30K
of Restricted Cash (Detail)
67: R44 Supplemental Balance Sheet Information - Summary HTML 36K
of Accrued Expenses (Detail)
68: R45 Leases - Additional Information (Detail) HTML 47K
69: R46 Leases - Schedule of effective lease cost HTML 31K
comprehensive income loss (Details)
70: R47 Leases - Summary of Future Minimum Lease Payments HTML 39K
Due Under Operating Leases (Details)
71: R48 Note Payable - Additional Information (Details) HTML 76K
72: R49 Note Payable - Carrying Value of Note Payable HTML 32K
(Details)
73: R50 Common Stock - Additional Information (Detail) HTML 70K
74: R51 Common Stock - Summary of Common Stock Reserved HTML 46K
for Future Issuance (Detail)
75: R52 Stock-Based Compensation - Additional Information HTML 91K
(Detail)
76: R53 Stock-Based Compensation - Summary of Assumptions HTML 33K
that Used to Determine Grant-Date Fair Value of
Stock Options Granted to Employees and Members of
Board (Detail)
77: R54 Stock-Based Compensation - Summary of Stock Option HTML 61K
Activity (Detail)
78: R55 Stock-Based Compensation - Summary of Restricted HTML 55K
Stock Award and Restricted Stock Unit Activity
(Detail)
79: R56 Stock-Based Compensation - Schedule of Stock-based HTML 33K
Compensation Expense (Detail)
80: R57 401(k) Savings Plan - Additional Information HTML 33K
(Detail)
81: R58 Income Taxes - Additional Information (Detail) HTML 62K
82: R59 Income Taxes - Schedule of Reconciliation of HTML 50K
Income Tax Expense (Benefit) (Detail)
83: R60 Income Taxes - Schedule of Deferred Tax Assets and HTML 58K
Liabilities (Detail)
84: R61 Net Income (Loss) Per Share - Components of Basic HTML 56K
and Diluted Earnings Per Share (Details)
85: R62 Net Income (Loss) Per Share - Schedule of Dilutive HTML 33K
Common Stock Equivalents Excluded from Computation
of Diluted Net Loss per Share (Detail)
86: R63 Related Party Transactions - Additional HTML 44K
Information (Detail)
87: R64 Restructuring - Additional Information (Details) HTML 56K
88: R65 Restructuring - Schedule of Restructuring HTML 37K
Activities (Details)
89: R66 Subsequent Events - Additional Information HTML 33K
(Details)
20: XML IDEA XML File -- Filing Summary XML 152K
23: XML XBRL Instance -- d770053ds4a_htm XML 1.23M
19: EXCEL IDEA Workbook of Financial Report Info XLSX 150K
15: EX-101.CAL XBRL Calculations -- avro-20231231_cal XML 112K
16: EX-101.DEF XBRL Definitions -- avro-20231231_def XML 541K
17: EX-101.LAB XBRL Labels -- avro-20231231_lab XML 1.19M
18: EX-101.PRE XBRL Presentations -- avro-20231231_pre XML 838K
14: EX-101.SCH XBRL Schema -- avro-20231231 XSD 194K
21: JSON XBRL Instance as JSON Data -- MetaLinks 444± 653K
22: ZIP XBRL Zipped Folder -- 0001193125-24-076669-xbrl Zip 3.19M
| EX-FILING FEES |
Exhibit 107
Calculation of Filing Fee Tables
Form S-4
(Form Type)
AVROBIO, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1 - Newly Registered and Carry Forward Securities
| Security Type |
Security Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Price |
Fee Rate |
Amount of Registration Fee |
Carry Form |
Carry Forward File Number |
Carry Forward Initial effective date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
|
Fees to Be Paid |
— | — | — | — | — | — | — | — | ||||||||||||||||
|
Fees Previously Paid |
Equity |
Common per share |
Other | 104,564,992 (1) | (2) | $403.49 (2) | $0.0001476 | $0.06 | ||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
|
Carry Forward Securities |
— | — | — | — | — | — | — | — | — | |||||||||||||||
| Total Offering Amounts | $403.49 (2) | $0.06 | ||||||||||||||||||||||
| Total Fees Previously Paid | $0.11 | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $0.00 | |||||||||||||||||||||||
| (1) | Relates to common stock, $0.0001 par value per share, of AVROBIO, Inc., a Delaware corporation (“AVROBIO”), that are expected to be issued (or become issuable) to securityholders of Tectonic Therapeutic, Inc., a Delaware corporation (“Tectonic”), in the proposed merger of Alpine Merger Subsidiary, Inc., a Delaware corporation and a direct, wholly owned subsidiary of AVROBIO, with and into Tectonic, with Tectonic surviving as a wholly owned subsidiary of AVROBIO and being the surviving corporation of the merger. The amount of common stock of AVROBIO to be registered includes the estimated maximum number of shares of common stock of AVROBIO that are expected to be issued (or become issuable) pursuant to the merger, without taking into account the effect of a reverse stock split of common stock of AVROBIO, assuming an estimated pre-split exchange ratio (which is subject to adjustment prior to the closing of the merger) of approximately 7.44585749 shares of common stock of AVROBIO for each outstanding share of common stock of Tectonic. In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any securities that may be from time to time be offered or issued resulting from forward or reverse stock splits, stock dividends or similar transactions. |
| (2) | Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(f)(2) of the Securities Act of 1933, as amended. Tectonic is a private company, no market exists for its securities, and it has an accumulated capital deficit. Therefore, the proposed maximum aggregate offering price for the shares expected to be issued pursuant to the merger is one-third of the aggregate par value of the Tectonic securities expected to be exchanged in the proposed merger. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/15/24 AVROBIO, Inc. S-4/A 91:17M Donnelley … Solutions/FA |